Hans Fünfschilling

Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland.

Arpida AG develops and discovers drugs for microbial resistance. The company's products include intravenous iclaprim, and antibiotics. The antibiotics provides resistance towards the methicillin-resistant Staphylococcus aureus (MRSA). The company also discovers an oral formulation of iclaprim. The company was founded by Dr. Dieter Gillessen, Bernhard Erni and Dr. Ivan Kompis in July 1997 and is headquartered in Reinach, Switzerland.

Endress+Hauser AG manufactures measuring instruments and automation solutions for the industrial process engineering industry. The company was founded in 1953 and is headquartered in Reinach, Switzerland.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Endress+Hauser Holding AG manufactures instrumentation and measurement systems. It offers instruments to control automation processes for analytics, flow measurement, level, pressure, and temperature fields. The firm provides inventory management, flow metering, analytical, filed networking engineering and plant asset management solutions, and supporting and optimizing services for oil and gas, power and energy, water and wastewater, life sciences, food and beverage, and chemical industries. The company was founded in 1953 and is headquartered in Reinach, Switzerland.